ARCHIVES

Reinventing NCI: Clinical Trials System Changes Not Easy Or Quick, Klausner Says; NCAB Members, Others, Sound Off On Group’s Report

This article is from The Cancer Letter archive.

Vol. 23 No. 39 | October 10, 1997

Download PDF Visit The Full Archive

Related Articles

Gori Tells McGovern Committee Diet Causes Major Share Of Cancer

August 6, 1976

House Committee Asks Varmus About Impact of Clinical Center construction On NIH Programs

April 26, 1996

FDA Approves Femara As First-Line Treatment For Advanced Breast Cancer.

January 26, 2001

ASCO Ends Early Distribution Of Abstracts To Halt “ASCO Effect” On Stock Market

January 24, 2003

Kadcyla Extends Median PFS In Open-Label Phase III Trial

October 25, 2013

Concept Approved For New Quality Assurance Center

May 14, 1982